Barrier Systems Conference

Objectives

This is why you will benefit from attending this conference:

• Case studies from various pharmaceutical companies deal with the implementation, qualification and operation of Isolators, RABS and Robots.
• You will discuss the current state of the art and new technological developments in Barrier Systems and Pharmaceutical Robotics Technology.
• You will learn first-hand about the new EU GMP Annex 1 requirements for barrier systems and how these requirements are interpreted and inspected by inspectors.
• Experts from pharmaceutical companies will share their knowledge regarding operational experience.

Registration

Background

The protection against microbial contamination is the most important point for drugs produced by aseptic processes. Today the regulators require a stricter separation between operators and product in the form of an access barrier.  

Two systems are on the market – RABS (Restricted Access Barrier System) and Isolators. But only isolators are referred to by the US FDA as advanced aseptic technology. Another consequence of the separation of operator and production process is the increased introduction of Gloveless Isolators and Robot Technology in the aseptic environment.
This conference will focus on current questions of barrier systems and robotics coming from FDA regulations as well as from the revised EU-GMP Annex 1, and it will specifically address the subject from the perspectives of pharmaceutical operators, planners and engineers.

Target Audience

This event is directed at decision-makers from pharmaceutical production, automation, development and quality assurance/control. It also addresses engineers and planners who need to be well informed about current developments in the field of barrier systems and robotics.